Profile
| Role | Director |
|---|---|
| Notability | 20/100 |
Board memberships
- Prime Medicine, Inc.
Updated Jul 16, 2026
Foster-Cheek Kaye I has filed 2 SEC Form 4 filings across 2 companies in the last 90 days.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-23 | AGIO | AGIOS PHARMACEUTICALS, INC. | M — Option exercise | 2.8K | $0.00 |
Foster-Cheek Kaye I is a corporate insider — currently tracked as Director of AGIOS PHARMACEUTICALS, INC. (AGIO). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 2 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Foster-Cheek Kaye I profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.